Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents.
about
Gd-DTPA-Dopamine-Bisphytanyl Amphiphile: Synthesis, Characterisation and Relaxation Parameters of the Nanoassemblies and Their Potential as MRI Contrast Agents.Predicting the release profile of small molecules from within the ordered nanostructured lipidic bicontinuous cubic phase using translational diffusion coefficients determined by PFG-NMR.Enhancement of biological activities of nanostructured hydrophobic drug species.Chelating DTPA amphiphiles: ion-tunable self-assembly structures and gadolinium complexes.Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design.Nanoparticles as delivery carriers for anticancer prodrugs.Nanostructured liquid-crystalline particles for drug delivery.The application of nanosponges to cancer drug delivery.Oral bioavailability: issues and solutions via nanoformulations.Advances in oral delivery of anti-cancer prodrugs.Lipid-Drug Conjugate for Enhancing Drug Delivery.Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory PhytocompoundsNanomedical research in Australia and New Zealand.The role of solvent swelling in the self-assembly of squalene based nanomedicines.Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging.Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity.Direct demonstration of lipid phosphorylation in the lipid bilayer of the biomimetic bicontinuous cubic phase using the confined enzyme lipid A phosphoethanolamine transferase.
P2860
Q30993842-2CAE8CA4-312F-4097-8B11-9B69BCA2D9D8Q31152387-B9CDD7EB-43C9-48E3-8BFD-514749F473CAQ33453351-8680E2B8-F822-4859-91F5-D26E443AF149Q34378765-D82EE612-6EA6-4D19-895C-BE6E7102157AQ37626466-D6AEE77B-5D76-49C3-8F61-A53A2DD9BAC8Q37942744-2E60381B-5755-4CE2-9B90-C7FE89602C9CQ38002956-8A2D2BD0-62D1-47CE-9C00-F4CD2E073B36Q38184591-B6DF1733-2817-46B0-B23F-88D739F493CDQ38210423-5DE3538E-FB88-43F5-9F8B-6095D8246EC5Q38349734-926DA022-2CDD-4D9D-A7E1-0A8B27F2389DQ38862820-6F495025-54DB-4569-A45D-E6CF917AF53FQ39083391-5554556E-E1E4-4413-A270-581B7B336146Q39122521-CAD96486-CC9D-4B3A-A3FF-5DAD984BAD58Q39204729-5F0F1CDC-B441-47D1-B38D-C67D0A7AD2DAQ39307127-FFD75590-3DE4-442E-AC35-A92DF0FA96ABQ39419981-B693DE17-836F-4627-BF41-09F0201272FAQ41605836-A617557B-226B-463E-B043-9F1BF39CCE7BQ41606644-3D841818-3611-4FA7-9783-B15A62BA6861Q48308753-FCD4D7AB-CA79-468C-AAC5-C053A1D20B18
P2860
Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@en
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@nl
type
label
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@en
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@nl
prefLabel
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@en
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@nl
P2093
P2860
P921
P356
P1433
P1476
Nanostructured nanoparticles o ...... roved chemotherapeutic agents.
@en
P2093
Irena Krodkiewska
Kathleen Kimpton
Lynne J Waddington
Minoo J Moghaddam
Sharon M Sagnella
Xiaojuan Gong
P2860
P304
P356
10.1039/C0NR00781A
P407
P577
2010-12-21T00:00:00Z